Abstract Details
Ralph Z. Kern, MD
(Cognito Therapeutics)
PRESENTER |
Dr. Kern has received personal compensation for serving as an employee of Cognito Therapeutics. |
ZD Kuang (Cognito Therapeutics, Inc) | No disclosure on file |
Mihaly Hajos, PhD (Cognito Therapeutics) | Prof. Hajos has received personal compensation for serving as an employee of Cognito Therapeutics, Inc. Prof. Hajos has stock in Cognito Therapeuitcs. Prof. Hajos has stock in Biogen. Prof. Hajos has stock in Pfizer. Prof. Hajos has received intellectual property interests from a discovery or technology relating to health care. |
Alex Konisky (Cognito Therapeutics) | No disclosure on file |
Alyssa Boasso (Cognito) | No disclosure on file |
Evan Hempel (Cognito Therapeutics) | No disclosure on file |
Brent Vaughan (Cognito Therapeutics, Inc.) | No disclosure on file |
Chandran Seshagiri (Cognito Therapeutics) | No disclosure on file |
Zach Malchano (Cognito Therapeutics) | Mr. Malchano has received personal compensation for serving as an employee of Cognito Therapeutics, Inc.. Mr. Malchano has received stock or an ownership interest from Cognito Therapeutics. |
Suzanne Hendrix, PhD | Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has stock in Pentara. |
Khalil Saikali | No disclosure on file |
Joseph Massey (SSI Strategy) | No disclosure on file |
Ramesh Arjunji | No disclosure on file |